Skip to menu Skip to content Skip to footer

2025

Journal Article

Peripheral and central elevation of IL-8 in patients with Huntington’s disease

Fung, Jenny N., Lee, John D., Adam, Robert, O’Sullivan, John D. and Woodruff, Trent M. (2025). Peripheral and central elevation of IL-8 in patients with Huntington’s disease. Molecular Immunology, 179, 84-93. doi: 10.1016/j.molimm.2025.02.003

Peripheral and central elevation of IL-8 in patients with Huntington’s disease

2025

Journal Article

Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience

Yeow, Dennis, Fielder, Matthew, Hynard, Shane, Adam, Robert, Katz, Matthew, Lehn, Alexander, Thomas, Paul and O'Sullivan, John D. (2025). Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience. Internal Medicine Journal, 55 (2), 207-215. doi: 10.1111/imj.16615

Clinical utility of 18F-fluorodopa positron emission tomography in the movement disorder clinic: an Australian experience

2024

Journal Article

Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data

Pourzinal, Dana, Lawson, Rachael A., Yarnall, Alison J., Williams‐Gray, Caroline H., Barker, Roger A., Yang, Jihyun, McMahon, Katie L., O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2024). Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data. Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, 16 (3) e12625, 1-11. doi: 10.1002/dad2.12625

Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD data

2024

Journal Article

Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's disease

Pourzinal, Dana, Yang, Jihyun, McMahon, Katie L., Copland, David A., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2024). Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's disease. Brain and Behavior, 14 (3) e3454, 1-12. doi: 10.1002/brb3.3454

Hippocampal resting‐state connectivity is associated with posterior‐cortical cognitive impairment in Parkinson's disease

2024

Journal Article

A physiotherapy group exercise and self-management approach to improve physical activity in people with mild-moderate Parkinson’s disease: a randomized controlled trial

Brauer, Sandra G., Lamont, Robyn M. and O’Sullivan, John D. (2024). A physiotherapy group exercise and self-management approach to improve physical activity in people with mild-moderate Parkinson’s disease: a randomized controlled trial. Trials, 25 (1) 76, 1-10. doi: 10.1186/s13063-023-07870-4

A physiotherapy group exercise and self-management approach to improve physical activity in people with mild-moderate Parkinson’s disease: a randomized controlled trial

2024

Journal Article

Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease

Roper, Amy, Brooks, Deborah, Mitchell, Leander K., Pachana, Nancy A., Au, Tiffany R., Byrne, Gerard J., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2024). Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease. Clinical Gerontologist, 1-16. doi: 10.1080/07317115.2024.2306861

Feasibility and acceptability of a videoconferencing CBT intervention for anxiety in people with Parkinson’s Disease

2023

Journal Article

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

Dissanayaka, Nadeeka, Pourzinal, Dana, Byrne, Gerard J., Yang, Jihyun, McMahon, Katie L., Pontone, Gregory M., O'Sullivan, John D., Adam, Robert, Littleford, Roberta, Chatfield, Mark, Lehn, Alexander, Mari, Zoltan and Bakker, Arnold (2023). Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol. Pilot and Feasibility Studies, 9 (1) 189, 189. doi: 10.1186/s40814-023-01406-y

Levetiracetam for the treatment of mild cognitive impairment in Parkinson's disease: a double-blind controlled proof-of-concept trial protocol

2023

Journal Article

Pareidolias are a function of visuoperceptual impairment

McCann, Emily, Lee, Soohyun, Coleman, Felicia, O’Sullivan, John D. and Nestor, Peter J. (2023). Pareidolias are a function of visuoperceptual impairment. PLoS One, 18 (11) e0293942, 1-11. doi: 10.1371/journal.pone.0293942

Pareidolias are a function of visuoperceptual impairment

2023

Journal Article

Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease

Pourzinal, Dana, Yang, Jihyun, Sivakumaran, Kumareshan, McMahon, Katie L., Mitchell, Leander, O'Sullivan, John D., Byrne, Gerard J. and Dissanayaka, Nadeeka N. (2023). Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease. Brain and Behavior, 13 (10) e3218, e3218. doi: 10.1002/brb3.3218

Longitudinal follow up of data‐driven cognitive subtypes in Parkinson's disease

2023

Journal Article

Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease

Yang, Jihyun, Pourzinal, Dana, Byrne, Gerard J., McMahon, Katie L., Copland, David A., O’Sullivan, John D., Mitchell, Leander and Dissanayaka, Nadeeka N. (2023). Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease. International Journal of Geriatric Psychiatry, 38 (6) e5955, e5955. doi: 10.1002/gps.5955

Global assessment, cognitive profile, and characteristics of mild cognitive impairment in Parkinson's disease

2023

Journal Article

A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation

Jayabalan, Nanthini, Oronsky, Bryan, Cabrales, Pedro, Reid, Tony, Caroen, Scott, Johnson, Aishwarya M., Birch, Natalia A., O’Sullivan, John D. and Gordon, Richard (2023). A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation. Drugs, 83 (5), 389-402. doi: 10.1007/s40265-023-01838-z

A review of RRx-001: a late-stage multi-indication inhibitor of NLRP3 activation and chronic inflammation

2022

Journal Article

Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment

Yang, Jihyun, McMahon, Katie L., Copland, David A., Pourzinal, Dana, Byrne, Gerard J., Angwin, Anthony J., O’Sullivan, John D. and Dissanayaka, Nadeeka N (2022). Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment. Brain Imaging and Behavior, 16 (6), 1-12. doi: 10.1007/s11682-022-00698-7

Semantic fluency deficits and associated brain activity in Parkinson’s disease with mild cognitive impairment

2022

Journal Article

Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality

Zhang, Angeline, Mitchell, Leander K., Pachana, Nancy A., Yang, Ji Hyun J., Au, Tiffany R., Byrne, Gerard J., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2022). Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality. International Psychogeriatrics, 34 (7) PII S1041610221002866, 1-8. doi: 10.1017/s1041610221002866

Caring for a loved one with Parkinson’s disease: the role of coping styles and relationship quality

2021

Journal Article

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trial

Vivash, Lucy, Bertram, Kelly L, Malpas, Charles B, Marotta, Cassandra, Harding, Ian H, Kolbe, Scott, Fielding, Joanne, Clough, Meaghan, Lewis, Simon J G, Tisch, Stephen, Evans, Andrew H, O'Sullivan, John D, Kimber, Thomas, Darby, David, Churilov, Leonid, Law, Meng, Hovens, Christopher M, Velakoulis, Dennis and O'Brien, Terence J (2021). Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trial. BMJ Open, 11 (12) e055019, e055019. doi: 10.1136/bmjopen-2021-055019

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: Protocol for a phase 2, randomised, double-blind, placebo-controlled trial

2021

Journal Article

Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia

Dissanayaka, Nadeeka N., Forbes, Elana J., Yang, Ji Hyun J., Pourzinal, Dana, O’Sullivan, John D., Mitchell, Leander K., Copland, David A., McMahon, Katie L. and Byrne, Gerard J. (2021). Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia. Journal of Neurology, 269 (3), 1600-1609. doi: 10.1007/s00415-021-10736-x

Anxiety disorders are associated with verbal memory impairment in patients with Parkinson’s disease without dementia

2021

Journal Article

Defining atypical anxiety in Parkinson's disease

Forbes, Elana J., Byrne, Gerard J., O'Sullivan, John D., Yang, Jihyun, Marsh, Rodney and Dissanayaka, Nadeeka N. (2021). Defining atypical anxiety in Parkinson's disease. Movement Disorders Clinical Practice, 8 (4), 571-581. doi: 10.1002/mdc3.13193

Defining atypical anxiety in Parkinson's disease

2021

Journal Article

Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairment

Yang, Jihyun, Pourzinal, Dana, McMahon, Katie L., Byrne, Gerard J., Copland, David A., O’Sullivan, John D. and Dissanayaka, Nadeeka N. (2021). Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairment. Parkinsonism and Related Disorders, 85, 17-22. doi: 10.1016/j.parkreldis.2021.02.009

Neural correlates of attentional deficits in Parkinson’s disease patients with mild cognitive impairment

2021

Journal Article

Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study

Evans, Andrew, Fung, Victor S. C., O'Sullivan, John D., Stell, Rick, White, Richard, Williams, David R., Femia, Samira and Onuk, Koray (2021). Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study. Clinical Parkinsonism and Related Disorders, 4 100075, 100075. doi: 10.1016/j.prdoa.2020.100075

Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics - Australian results from the cross-sectional OBSERVE study

2020

Journal Article

Differential patterns of internally generated responses in parkinsonian disorders

Tjokrowijoto, Priscilla, Ceslis, Amelia, O'Sullivan, John D., Adam, Robert, Mellick, George, Silburn, Peter and Robinson, Gail A. (2020). Differential patterns of internally generated responses in parkinsonian disorders. Neuropsychologia, 146 107569, 107569. doi: 10.1016/j.neuropsychologia.2020.107569

Differential patterns of internally generated responses in parkinsonian disorders

2020

Journal Article

Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis

Pourzinal, Dana, Yang, Ji Hyun J., Byrne, Gerard J., O’Sullivan, John D., Mitchell, Leander, McMahon, Katie L., Copland, David A. and Dissanayaka, Nadeeka N. (2020). Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis. Journal of Neurology, 267 (11), 3213-3222. doi: 10.1007/s00415-020-09977-z

Identifying subtypes of mild cognitive impairment in Parkinson’s disease using cluster analysis